ID   LYOG
AC   CVCL_C8GP
DR   Wikidata; Q123032987
RX   PubMed=18698046;
CC   From: Childs, Richard W.; National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
RX   PubMed=18698046; DOI=10.1158/1078-0432.CCR-08-0028; PMCID=PMC2693478;
RA   Tykodi, Scott Simon
RA   Fujii, Nobuharu
RA   Vigneron, Nathalie
RA   Lu, Sharon M.
RA   Mito, Jeffrey K.
RA   Miranda, Maureen X.
RA   Chou, Jeffrey
RA   Voong, Lilien N.
RA   Thompson, John A.
RA   Sandmaier, Brenda M.
RA   Cresswell, Peter
RA   van den Eynde, Benoit J.
RA   Riddell, Stanley R.
RA   Warren, Edus Houston
RT   "C19orf48 encodes a minor histocompatibility antigen recognized by
RT   CD8+ cytotoxic T cells from renal cell carcinoma patients.";
RL   Clin. Cancer Res. 14:5260-5269(2008).
//